ASND — Ascendis Pharma A/S
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Ascendis Pharma A/S (ASND), worth $263.58M combined. Over the quarter 5 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $164.54M | 0.47% | +10.4% |
| ARS | $56.13M | 2.50% | +17.2% |
| Renaissance | $31.93M | 0.04% | +19% |
| Quadrature | $10.89M | 0.09% | NEW |
| Persistent | $87.22K | 0.03% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.